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a b s t r a c t
Johne’s disease (JD), or paratuberculosis is a fatal enteritis of animals caused by infection with Mycobacterium avium subspecies paratuberculosis (Map). There may be a long
subclinical phase with no signs of clinical disease.
Diagnosis of JD is problematic and no test can reliably detect sub-clinical disease. Th1
responses to Map are believed to be activated ﬁrst with a later switch to Th2 responses
and progression to clinical disease. Detection of a cell-mediated response, indicated by
interferon gamma (IFN-␥) produced in response to mycobacterial antigens, may give an
early indication of infection. Crude extracts of Map (PPDj) have been used to detect the
cell-mediated response, but more speciﬁc, quantiﬁable antigens would improve the test.
Thirty Map-speciﬁc proteins were screened for their ability to raise a cell-mediated
response in subclinically infected sheep. Four proteins were selected and tested using blood
from subclinical animals and controls from a JD-free ﬂock. Three proteins elicited IFN-␥
levels which were higher in the subclinical group than in the control group, two were statistically signiﬁcant. Thus these proteins have the ability to discriminate groups of infected
and uninfected animals and may have use in diagnosis of JD.
© 2013 Elsevier B.V. All rights reserved.

1. Introduction
Johne’s disease (JD), or paratuberculosis, is a fatal,
chronic granulomatous enteritis of animals caused by
Mycobacterium avium subspecies paratuberculosis (Map),
characterised by severe emaciation, poor body condition
and in some species diarrhoea. The disease is mainly spread
through ingestion of contaminated faecal material and
following infection, a long incubation period may ensue

Abbreviations: JD, Johne’s disease; IGRA, interferon gamma release
assay.
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during which there are no signs of clinical disease. These
subclinical animals may go undetected and infect their
herd-mates before clinical symptoms become apparent
(Sweeney et al., 1992; Chiodini, 1996; Toman et al., 2003).
The diagnosis of JD is problematic and no test can
reliably detect subclinical disease. Subclinical animals are
particularly difﬁcult to diagnose, they may be shedding
small numbers of Map in their faeces intermittently and
levels of circulating antibodies against Map may be low and
not detectable by ELISA tests. PCR detection or bacteriological culture of faeces may not be sufﬁciently sensitive to
detect low levels of organisms or may miss intermittent
shedders. Thus control programmes are hampered by the
inability to detect subclinical animals which fall below the
radar of currently available tests.
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Early detection of Map infection is desirable to lessen
the risks of transmission. The classical switch proﬁle has
been described for the immunological response of animals
to Map infection (Chiodini et al., 1984; Stabel, 2000, 2006),
in which Th1 responses are the ﬁrst to be activated. Thus
detection of a cell-mediated immune response by measuring the levels of interferon gamma (IFN-␥) produced
in response to mycobacterial antigens (often PPD) (Wood
et al., 1989) may give an early indication of subclinical
animals and may occur before faecal shedding or antibodies directed against Map can be detected (Benedixen,
1978; Chiodini, 1996). A drawback to the IFN-␥ test, which
is the requirement for fresh blood samples, has recently
been overcome by the addition of preservatives (IL-7, IL12 and anti-IL-10), which allows a lengthened time period
between collection and assay (Plain et al., 2012; Mikkelsen
et al., 2012).
PPDj is a crude extract of Map and contains many
antigenic components shared with the closely related environmental organism M. avium subspecies avium and with
other pathogenic mycobacteria including M. bovis. Thus use
of PPDj has issues for quality control and speciﬁcity. Substitution of PPD by speciﬁc recombinant proteins would
greatly enhance the conﬁdence in this test to diagnose Map
infection and allow deﬁnition and quantiﬁcation of antigen in the assay. Recently, Map recombinant proteins have
been used to improve the speciﬁcity of the response in cattle (Mikkelsen et al., 2011). Here we describe a study to
determine the efﬁcacy of different Map recombinant proteins to elicit a Th1 response in naturally exposed sheep
obtained from a ﬂock with a history of JD and identify three
recombinant proteins, which may have the ability to detect
early Map infection when incorporated into an interferon
gamma release assay (IGRA).

2.3. Blood collection from sheep
Blood was collected by venipuncture in vacutainer
tubes (those for IGRA contained preservative-free heparin).
Experimental procedures were assessed and approved by
an Experiments and Ethics Committee and authorised
under the Animals (Scientiﬁc Procedures) Act 1986.
2.4. Preparation of PBMCs
PBMCs were prepared from buffey coat of heparinised
blood using lymphoprep (Nycomed). Residual erythrocytes were removed by hypotonic lysis. PBMCs were
suspended in RPMI complete (RPMI 1640 [84%, v/v],
foetal bovine serum [10%, v/v], glutamine [1 mM], penicillin [100 U/ml], streptomycin [100 g/ml], gentamycin
[100 g/ml], ␤-mercapto ethanol [50 M], sodium bicarbonate [0.08%, w/v], HEPES [25 mM]), counted and adjusted
to 2 × 106 cells per ml.
2.5. Incubation of blood with antigen
Whole blood (750 l) or 500 l of PBMCs, were
incubated with either PPDa (purchased from AHVLA Weybridge), PPDj or puriﬁed recombinant protein added in
a volume of 50 l to a ﬁnal concentration of 2.5, 2.5 or
10 g/ml, respectively. ConA or SEB (ﬁnal concentrations
of 5 or 1 g/ml, respectively) were used as stimulation
controls, media controls (either RPMI or PBS) were also
included. Stimulated blood was incubated in 5% (v/v) CO2
for 24 h, centrifuged (500 g, 5 min at room temperature)
and approx 500 l supernatant removed and stored at
−70 ◦ C until required.

2. Materials and methods

2.6. BovigamTM IFN- release assay

2.1. Selection of subclinically infected animals

The IGRAs were performed as described by the manufacturer. Ovine IFN-␥ standards ranging from 0 to 5000 pg/ml
were assayed on each plate analysed. This data enabled
calculation of the amount of IFN-␥ released during the
stimulation. Alternatively, ODs were calibrated according
to the OD-values of the positive and negative controls on
the respective plates as described previously (Jungersen
et al., 2002).

Subclinically infected animals were selected from two
farms. Farm A had a high prevalence of ovine JD, with 27
clinical cases diagnosed between 2002 and 2008. Of these,
22 were classiﬁed as paucibacillary and the remainder as
multibacillary disease following histopathological examination. Farm B had a low prevalence of JD with only one
clinical case conﬁrmed by tissue culture over the same
period. The ﬂocks on the farms were screened using the
BovigamTM (Celtic Diagnostics Ltd, Dublin, Ireland) IGRA.
Whole blood was stimulated with PPDj and incubated for
24 h and the IGRA was performed. Animals producing more
than 400 pg/ml of IFN-␥ were considered responders and
subclinically infected. These animals did not show any
clinical signs of JD and were transported to the Moredun
Research Institute where they were housed until the end
of the study.
2.2. Selection of control animals
Control animals were sourced from Farm C with no history of clinical JD. Animals were negative in the following
tests: BovigamTM IGRA, JD serum ELISA and faecal culture.

2.7. JD antibody ELISA test
Blood samples were commercially tested for serum
antibody (Biobest Midlothian, UK) using the JD ELISA test
(Institute Pourquier, Montpellier, France).
2.8. Preparation of recombinant proteins
Thirty recombinant Map proteins, previously identiﬁed
as potentially Map-speciﬁc were tested. Maltose Binding
Protein (MBP)-fusion recombinant proteins were cloned
and puriﬁed (Hughes et al., 2008). Protein solutions were
either diluted in RPMI complete for PBMC stimulation or
PBS for whole blood stimulations.
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2.9. Post mortem and histopathology
Animals were euthanized with an intravenous injection of 100 mg/kg pentobarbital. Samples of ileum, distal
jejunum (DJ), mesenteric lymph node (MLN), ileo-caecal
valve (ICV) and ileo-caecal lymph node (ICLN) were collected, and ﬁxed in 10% buffered formalin saline to be
processed for histology. Samples of MLN, terminal ileum
(TI) and ICLN were removed for bacteriological culture.
Microscopical examination was performed on parafﬁnwax embedded, 5 m-thick sections mounted on glass
microscope slides and stained with haematoxylin and
eosin (H&E) and Ziehl–Neelsen staining (ZN) for acid-fast
bacteria. Animals were classiﬁed as paucibacillary or multibacillary according to the criteria described by Clarke and
Little (1996).
2.10. Bacteriological culture from post mortem tissues
Tissue sections (either fresh or previously frozen
at −80 ◦ C) were trimmed of fat and connective tissue, homogenised, decontaminated and used to inoculate slopes of Middlebrook 7H11 supplemented with
mycobactin J as described previously (Hughes et al., 2007).
MLN and TI were submitted for bacteriological culture for
all animals, ICLN was also submitted from W363, PC212, P7
and 4349.
2.11. Bioinformatics
Kyoto encyclopedia of genes and genomes (KEGG) was
used to retrieve gene sequences. The SOSUI system for classiﬁcation and secondary structure prediction was used to
determine the likelihood of these proteins being membrane associated (Hirokawa et al., 1998).
2.12. Statistical analysis
Because of the small number of observations per animal and the presence of heterogeneity in variance of the
status of animal, a linear model using generalised leastsquares was ﬁtted to the OD data. The infection status of
animals, recombinant protein and the interaction of these
factors were ﬁtted as categorical ﬁxed effects. The heterogeneity in variance associated with the status of animal was
explicitly modelled. The estimate of the residual variance
component was obtained by the Restricted Maximum Likelihood (REML) method (Pinheiro and Bates, 2000). To take
into account the multiple comparisons of several proteins,
the p-values estimated under the ﬁtted model for each pairwise comparison were adjusted so that the overall false
discovery rate was 5% (Benjamini and Hochberg, 1995). All
statistical analyses were carried out using the R software
version 2.13.1 (R Core Team, 2012).
3. Results and discussion
Naturally infected ﬂocks were utilised to establish a
panel of sheep identiﬁed by IGRA screening; selecting individuals with no clinical signs of disease but elevated IFN-␥
responses to PPDj. The assumption was that the selected
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animals had been exposed to Map and were subclinically
infected. Thirty recombinant proteins were tested for their
ability to elicit IFN-␥ production in PBMCs of nine subclinical sheep, results are presented in Table 1.
Animals showing production of IFN-␥ in excess of
50 pg/ml were deemed to have responded to the antigen.
Responses of animals to individual proteins varied considerably, no two animals responded to the same subset. Of
the 30 recombinant Map proteins investigated, all were
deemed to elicit a IFN-␥ response in at least one animal.
Some animals were particularly responsive to the protein
antigens whilst others had limited responses. Four proteins
(MAP1297, MAP1365, MAP3651c and MAP0268c), were
selected for further investigation primarily on the basis of
the number of animals exhibiting a response and its magnitude.
The likelihood of the selected proteins being membrane associated was determined using the SOSUI
system, only MAP0268c was indicated as membraneassociated, and is a hypothetical protein with a thiopurine
S-methyltransferase motif. The other proteins were
predicted as soluble and annotated as phosphoribosyl
isomerise (MAP1297), ornithine carbamoyltransferase
(MAP1365) both involved in amino acid biosynthesis, and
FADE3 2 (MAP3651c) central to terpenoid and geraniol
metabolism. To assess the diagnostic potential of the
selected proteins, IFN-␥ responses of subclinical and uninfected animals were compared. Six subclinical animals
from Farm A (P7, P33, W363, W395, PC212, 0269) and four
control animals (724A, 329A, 307A, and 463A) selected at
random from Farm C were used in this study. Whole blood
was used rather than PBMCs for the IGRA as this would be
the sample of choice for diagnostic testing. IGRAs on whole
blood were carried out in duplicate with the selected
proteins, MBP, and PPDa and data were analysed (Fig. 1A).
The mean OD value for each blood sample tested was
calibrated and corrected for the contribution of MBP to the
stimulation. The data showed heterogeneity in variance
for the status of infection and it was noted that the OD
value of one of the animals in the infected group stimulated with MAP0268c was an order of magnitude higher
than the other comparable readings and considered an
outlier.
Statistical analysis of data following exclusion of the
outlier (observation on animal W363 for MAP0268c)
showed that the interaction effect of treatment group
and protein was statistically signiﬁcant (p = 0.022) which
indicated that there was evidence of genuine differences
in mean responses between the control and subclinical
animal groups for some of the proteins. For all proteins,
mean levels were higher in the subclinical group and the
means were markedly different for MAP0268c, MAP1365
and MAP3651c. For the recombinant protein MAP3651c,
the mean OD value (±standard error of mean) of the
infected group (0.198 ± 0.035) was statistically signiﬁcantly (false discovery rate-adjusted p = 0.010) higher than
the mean OD value of the control group (0.015 ± 0.043).
Additionally, for the protein MAP0268c, there was weak
evidence (FDR-adjusted p = 0.051) that the mean OD value
of the infected group (0.051 ± 0.017) was higher than the
mean OD value of the control group (−0.009 ± 0.019). The
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Table 1
IFN-␥ responses to recombinant Map antigens in subclinical animals.

P7
MAP0068
MAP0139c
MAP0268c
MAP0334
MAP1012c
MAP1160c
MAP1293
MAP1297
MAP1365
MAP1564c
MAP1754c
MAP2541c
MAP2685
MAP2872c
MAP2878c
MAP3175
MAP3205
MAP3385
MAP3457
MAP3491
MAP3540c
MAP3567
MAP3627
MAP3651c
MAP3692c
MAP3841
MAP3857
MAP3932c
MAP4147
MAP4233

P15

P33

W363

PC212

W395

O269

1707N

/

/

1585N
/
/

ND
/

/

/

/

/
ND
ND

ND
ND
/
/
/

/
ND
/

ND
ND
ND

/
/

/
ND
/
/

/
/

/
/

/
/
/

/
/
/

/
/
/
/

/

ND
/
ND
ND

ND
/
/

/

/
/

/
/

Number of responders

2
3
6
6
5
3
3
6
5
4
2
4
4
3
5
5
1
4
2
4
2
4
2
7
4
1
4
2
5
3

< 50 pg
> 50 pg<100pg IFN-γ
> 100pg IFN-γ
ND
not determined
Proteins which were selected for further investigation are highlighted.
/

difference of the mean OD values of infected and control
groups for MAP1365 was short of statistical signiﬁcance
(p = 0.16) and that for MAP1297 protein was also not
statistically signiﬁcant.
Inclusion of the outlying data point vastly increased
the mean OD for the infected animal group but also
increased the observed variation and the observed effect
ceased to be statistically signiﬁcant. Exclusion of the data
point is not unreasonable given that technical errors
in plate manipulation can lead to spurious high OD
readings.
During the period of recombinant antigen testing,
responses of animals to PPDj were also monitored and
the results are presented in Fig. 1B. All animals (except
P15) exhibited consistently high levels of IFN-␥ production in response to PPDj, although a degree of ﬂuctuation

was observed. Despite this ﬂuctuation, most IGRA results
were in excess of the arbitrary 400 pg/ml cut off we had
applied in selecting the animals for investigation. Animal P15 however, demonstrated the classical IFN-gamma
response pattern in JD (Stabel, 2000), in that it responded
highly to PPDj in the subclinical stage (day 1-levels in
excess of 500 pg ml−1 ), but the response was lost rapidly
after transport to Moredun (0–5 pg ml−1 ) where it rapidly
succumbed to JD 30 days after purchase.
Subclinical animals were monitored (up to 4 years)
for IFN-␥ responses to PPDj and ELISA tests were performed periodically for detection of Map antibodies. Over
the course of the experiment, four animals were found to
have a positive JD antibody ELISA test (P15, PC212, P7 and
4349). Results of the repeated ELISA tests can be found in
supplementary Table S1.
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0.25
Control
Infected
0.20

OD

0.15

0.10

0.05

0.00

-0.05

MAP0268c

MAP1297

MAP1365

MAP3651c

Protein

B
IFN-γ concentration pg ml-1

3500
3000
P7
P15
P33
W363
PC212
W395
o269
1707N
1585N

2500
2000
1500
1000
500
0
*1

16

23

Day from first test

38

45

Fig. 1. (A) Mean OD values of infected and non-infected animals generated in BovigamTM IFN-␥ release assays. Whole blood was stimulated with four
recombinant antigens (MAP268c, MAP1297, MAP1365 and MAP3651c). The infected group comprised six animals sourced from a paratuberculosis-infected
ﬂock the control group comprised four animals sourced from a ﬂock with no history of paratuberculosis. The data was calibrated and corrected for the
contribution of MBP and medium to the stimulation. The error bar indicates the standard error of mean. (B) Temporal changes in IFN-␥ production of
whole blood from nine subclinical sheep in response to PPDj. OD values were generated in BovigamTM IFN-␥ release assays. Nine animals (P7, p15, P33,
W363, PC2121, W395, O269, 1707N, 1585N) sourced from paratuberculosis-infected farms were monitored periodically. The data was corrected for the
contribution of medium to the stimulation.

Supplementary material related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.vetimm.2013.06.015.
At the end of the study period, subclinical animals were
subjected to pathological and bacteriological investigations
to determine their infection or disease status with respect
to Map. A summary of this information including breed and
age is given in Table 2.
Histological examination of lymph nodes and intestine
samples from eight subclinical sheep was carried out. Three
had lesions previously described as paucibacillary (PC212,
P7, 4349) and samples of their ileum and lymph nodes
showed a severe inﬁltrate of small lymphocytes and multifocal small granulomata, with multinucleated giant cells.
In animals where macroscopic nodules were observed,
some of these granulomata were encapsulated and showed
evidence of calciﬁcation (Fig. 2B). ZN staining of these
samples did not show any acid-fast organisms. Macroscopic observations of the gastrointestinal tract showed
enlarged lymph nodes in two animals (PC212 and 4349)
and widespread formation of small, round, 1–2 mm diameter nodules on the surface of the small intestine and
lymph nodes of two sheep (P7 and 4349) (Fig. 2A). One
had lesions consistent with multibacillary JD (P15) (Fig. 2C

and D), changes in the ileum were characterised by sheets
of closely packed macrophages with abundant, weakly
eosinophilic cytoplasm, mainly seen in the mucosa. A
milder similar inﬁltrate was observed in the lamina propria,
submucosa and in the lymph nodes. ZN staining demonstrated a large number of acid-fast rods in the cytoplasm
of macrophages (Fig. 2D). Two further animals (0269 and
W395) had an inﬂammatory inﬁltrate characterised by
large amounts of eosinophils, some neutrophils and small
mineralised abscesses. The samples from the remaining
two animals (W363 and P33) were within normal histological limits (Table 2). The signiﬁcance of the small,
mineralised nodules observed macroscopically on the surface and within the tissues was difﬁcult to determine.
Similar lesions were reported previously in JD, but were
attributed to parasitic infection (Pérez et al., 1996). However, the cases described here had low parasitic loads and
an absence of parasitic debris. Mineralisation of lymph
node lesions has been described previously in JD-affected
wild ruminants (Williams et al., 1983; de Lisle et al.,
1993) so it is not implausible that the mineralised nodules
observed in this study were pathological lesions of JD.
Animal PC212 was one of the higher producers of
PPDj-stimulated IFN-␥ and had concomitant high levels
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Table 2
Summary of the post mortem pathological and bacteriological observations in the subclinical animals.
PC212♀

P7♀

4349♀b

0269♀

W395♀

P33♀

P15a ♀

General condition

Good

Good, but thin

Good

Good

Good

Good

Scouring and very thin

FEC
Breed

0
Bleu du
Maine X
8
GI tract, ICLN &
MLN normal

0
Bleu du
Maine X
8
GI tract normal
Enlarged ICLN
& MLN

Good, but
moderately
thin
0
Bleu du
Maine X
7
Wide spread
cysts/nodules
on surface of GI
tract, ICLN &
MLN and liver

0
Bleu du
Maine
7
GI tract, ICLN &
MLN appeared
normal

0
Bleu du
Maine
6
GI tract, ICLN &
MLN appeared
normal

0
Bleu du Maine X

High (6750/g)
Lleyn X

5
GI tract, ICLN & MLN
appeared normal

3.5
GI tract appeared
normal, enlarged MLN
and ICLN

Histopathology

No signiﬁcant
lesions in the
intestine or
lymph nodes.

Inﬂammatory
inﬁltrate in IM
& ISM mainly
eosinophil,
some
neutrophil. Old
abscesses in LN

Inﬂammatory
inﬁltrate in IM
& ISM mainly
eosinophil,
some
neutrophil.
Old abscess in
LN

No signiﬁcant changes
in the IM or LN.

Inﬂammatory inﬁltrate
(severe) of IM & ISM
(macrophage, some
eosinophil)
LN moderate numbers
macrophage

Map isolated from tissues
Diagnosis

No
Normal

Inﬂammatory
inﬁltrate of IM,
DJ, ICV and
liver
(eosinophils
and giant cells)
multifocal
small
granulomata,
encapsulated
with
calciﬁcation
+TI, ICLN
Paucibacillary

0
Bleu du
Maine X
6
Some
cysts/nodules
on surface of GI
tract, ICLN,
MLN & liver
MLN enlarged
with single cyst
Inﬂammatory
inﬁltrate J and
DJ LN
eosinophills
and giant cells
IM and ICV
normal

No
Parasitic
infection

No
Parasitic
infection

No
Normal

NDc
Multibacillary

Age (yrs) at PM/death
Gross pathology

Inﬂammatory
inﬁltrate of IM,
DJ, ICV, LN and
liver
(eosinophils
and giant cells)
multifocal
small
granulomata,
encapsulated
with
calciﬁcation
+TI, MLN, ICLN
Paucibacillary

+TI, MLN
Paucibacillary

FEC, faecal egg count; Strongylata, Nematodirus and Coccidia were identiﬁed in faecal material; TI, terminal Ileum; IM, ileal mucosa; ISM, ileal submuscosa; LN, lymph node; DJ, distal jejunum; ICLN, ileo-caecal
lymph node; ICV, ileo-caecal valve; MLN, mesenteric lymph node.
a
Died.
b
Animal recruited late to study and not used for screening recombinant antigens.
c
Not done, however,large numbers of acid fast bacilli were noted in IM, ISM and LN and faeces was culture positive for Map.
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Fig. 2. (A) Ileum of sheep P7 showing macroscopical widespread 1–2 mm diameter nodules and microscopical encapsulated granuloma (B) with numerous
multinucleated giant cells and calciﬁcation (H&E, original magniﬁcation ×200). (C) Multibacillary paratuberculosis (P15): very large number of macrophages
with abundant cytoplasm inﬁltrating ileal mucosa (H&E, original magniﬁcation ×200) and (D) stained with ZN (original magniﬁcation ×200).

of antibody. This case shows that high levels of antibody can exist alongside a well developed Th1 response,
which goes against the dogma of the switch hypothesis
(Chiodini et al., 1984; Stabel, 2000, 2006) and supports the
temporally coincident antibody/IFN-␥ responses for some
animals with JD as previously reported (Begg et al., 2011).
The ability of these proteins to discriminate between
subclinical and control animals indicates their potential as
diagnostic tools in IGRAs for the detection of subclinical
infections in sheep and their identiﬁcation is a step towards
a better diagnostic tool for JD. The mean OD values of all
antigens were lower than that obtained for PPDj stimulation of the infected group (0.7) which indicates that the
complex antigenic mix of PPDj was a more powerful stimulant of IFN-␥ production than any of the recombinant antigens. However, a mixture of the three antigens in a single
IGRA increased the magnitude of response and was effectively the sum of the individual parts (authors unpublished
observations). This indicates that cocktails of recombinant proteins maybe necessary to develop future sensitive
diagnostic tests. Although speciﬁcity of these proteins is
implied, an empirical approach to test the speciﬁcity of an
IGRA incorporating these proteins is still required.
The application of the IFN-␥ test for detection of individual animals likely to progress to clinical disease is still
debatable. Global differences of IFN-␥ response to PPD in
exposed and non-exposed populations was clearly demonstrated (Jungersen et al., 2012), but its ability to predict
shedding or clinical disease in individual animals was not

(Huda et al., 2004; Mikkelsen et al., 2009). In our study, four
out of eight sheep with elevated IFN-␥ release (in excess of
400 pg/ml) either had a positive diagnosis of paratuberculosis as deﬁned by the serum antibody ELISA or progressed
to it within the time scale of the experiment (2–3 years).
This high proportion of IGRA test positive animals which
progressed to diagnosis by the classical serum ELISA test
appears to be at odds with previous ﬁndings (Huda et al.,
2004). The likelihood of an exposed animal (as deﬁned
by IFN-␥ response) developing detectable infection (either
faecal shedding or a positive serum ELISA test) and the
impact of external factors is yet to be deﬁned and crucial for
determining the efﬁcacy of the IGRA to act as a prognostic
for JD.
A major drawback in control and eradication of JD is the
lack of tools to identify early-stage infections. Generation of
tools to monitor exposure of individual animals to Map may
provide a starting point to understand disease progression
and in ovine cases, may have applications in indicating animals which should be removed from ﬂocks to control the
spread of disease.
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